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Abstract
Clostridium difficile spores must germinate in vivo to become actively growing bacteria in order to produce the toxins that
are necessary for disease. C. difficile spores germinate in vitro in response to certain bile acids and glycine. In other
sporulating bacteria, proteins embedded within the inner membrane of the spore sense the presence of germinants and
trigger the release of Ca++-dipicolinic acid (Ca++-DPA) from the spore core and subsequent hydrolysis of the spore cortex, a
specialized peptidoglycan. Based upon homology searches of known germinant receptors from other spore-forming
bacteria, C. difficile likely uses unique mechanisms to recognize germinants. Here, we identify the germination-specific
protease, CspC, as the C. difficile bile acid germinant receptor and show that bile acid-mediated germination is important for
establishing C. difficile disease in the hamster model of infection. These results highlight the importance of bile acids in
triggering in vivo germination and provide the first description of a C. difficile spore germinant receptor. Blocking the
interaction of bile acids with the C. difficile spore may represent an attractive target for novel therapeutics.
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Introduction
Clostridium difficile infections (CDI) are steadily increasing in the
United States and other countries [1,2]. The use of broad-
spectrum antibiotics, often unrelated to CDI, leads to alteration of
the colonic microbiota that normally provides resistance to C.
difficile colonization [3]. In a host, C. difficile spores must germinate
to form the actively growing, anaerobic bacteria that produce the
two toxins that are necessary for disease (TcdA and TcdB) [4,5,6].
These two toxins are secreted by the bacterium where they then
enter host epithelial cells by receptor-mediated endocytosis and,
upon escape into the cytosol, glucosylate members of the Rho-
family of GTPases [7]. The action of these toxins lead to
symptoms normally associated with CDI (e.g. diarrhea) and release
of C. difficile spores into the environment [8].
Metabolically dormant spores are formed by selected bacterial
species in response to changes in environmental conditions,
including nutrient availability [9]. During spore formation, the
proteins required for germination are pre-packaged into the spore,
priming the spore to germinate when conditions are appropriate
[10]. In many spore-forming species, the interaction of the
metabolically dormant spore with specific germination-inducing
molecules (germinants) leads to the release of large amounts of
Ca++-dipicolinic acid (DPA) from the dehydrated spore core in
exchange for water. Subsequently, hydrolases embedded within
the spore cortex, a specialized peptidoglycan, become activated
and begin cortex hydrolysis. Once the core is rehydrated and the
cortex is degraded, a vegetative cell begins to grow out from the
germinated spore. This process is largely conserved among spore-
forming bacteria, though the signals that initiate germination can
vary. In Bacillus subtilis, L-alanine or a mixture of L-asparagine,
glucose, fructose and potassium ions triggers germination, while
spores of certain strains of Clostridium perfringens initiate germination
in response to inorganic phosphate and sodium ions [11].
The proteins that respond to these signals, ger receptors, share
homology among many spore-forming bacteria. However, based
on homology searches, C. difficile is not among the spore-forming
bacteria that have such canonical germinant receptors, suggesting
that C. difficile responds to unique germinants or uses a novel
mechanism for spore germination or both [12].
Approximately 30 years ago, Wilson and others showed that
certain bile acids increased the frequency of C. difficile colony
formation from environmental samples [13,14,15]. Bile acids are
small amphipathic, cholesterol-based molecules that aid in the
absorption of fats and cholesterol during digestion. Typically, the
liver synthesizes two main bile acids, cholic acid (3a,7a,12a-
trihydroxy-5b-cholanic acid) and chenodeoxycholic acid (3a,7a-
dihydroxy-5b-cholanic acid), which are further modified with the
addition of either a taurine or glycine amino acid [16]. Building on
the work of Wilson and others, we demonstrated that all cholic
acid derivatives can stimulate C. difficile colony formation from
spores with approximately equal efficiency [17]. Further, we
showed that exposure to the combination of taurocholic acid and
glycine were required to initiate C. difficile spore germination [17].
Interestingly, chenodeoxycholic acid was unable to stimulate
colony formation or the initiation of spore germination [17].
PLOS Pathogens | www.plospathogens.org 1 May 2013 | Volume 9 | Issue 5 | e1003356
Subsequent studies identified chenodeoxycholic acid as a compet-
itive inhibitor of cholic acid-mediated germination [18,19]. While
the chemical signals that promote the initiation of C. difficile spore
germination are known, the proteins that respond to these
germinants had not been identified.
Here, we applied a screen, previously used to identify loci
involved in B. subtilis spore germination [20], to the identification
of C. difficile germination-null phenotypes. Using a combination of
traditional chemical mutagenesis and contemporary massively
parallel DNA sequencing, we identified single nucleotide poly-
morphisms (SNPs) that give rise to ger phenotypes and character-
ized the resulting strains. We found that mutations in the C. difficile
cspC gene can abrogate the initiation of C. difficile spore
germination. Further, we identified a mutation in cspC that allows
chenodeoxycholic acid to act as a spore germinant, instead of an
inhibitor of germination. These results suggest that C. difficile CspC
is the bile acid-sensing germinant receptor. The identification of
the molecular target of bile acids on the C. difficile spore has
allowed us to test, for the first time, the in vivo role of bile acid-
mediated germination during C. difficile infection.
Results
Identifying germination-null phenotypes
Previously, we demonstrated that the cholic acid family of bile
acids causes spores to initiate germination in rich medium [17]. To
identify the C. difficile bile acid germinant receptor, we employed a
strategy schematized in Figure 1A. We mutagenized C. difficile
strain UK1 [19] using the DNA alkylating agent ethyl methane-
sulfonate (EMS). The EMS-mutagenized bacteria were allowed to
recover during overnight incubation in fresh medium and spread
on solid medium to allow efficient spore formation. Spores were
purified and incubated overnight at 37uC in rich medium+10%
w/v taurocholic acid [(TA); 185 mM] to germinate those spores
that were still able to respond to TA as a germinant. The spore
suspension (containing both germinated and non-germinated
spores) was incubated at 65uC for 30 minutes to heat-kill the
germinated spores; dormant, non-germinated spores are resistant
to 65uC. The surviving spores were artificially germinated using
thioglycollate and lysozyme [21] and then plated on rich medium
to recover, as colonies, the artificially germinated spores. Mutants
that failed to germinate under these conditions were enriched and
10 colonies, among thousands, were isolated and tested for the
ability of their spores to germinate in response to TA.
Spores from all 10 isolates (ger1–ger10) were unable to form
colonies on rich medium+TA, but did form colonies after artificial
germination [21] (Figure 1B; only wild-type C. difficile UK1 and ger
1 are shown). This suggests that the ger mutants are either blocked
at the outgrowth stage of germination (inability to grow as a
vegetative cell from the germinated spore) or blocked in the
initiation of germination (inability to respond to TA as a
germinant)
Characterizing germination-null C. difficile strains
To determine at what stage the mutants are blocked, we
analyzed the initiation of germination as measured by a decrease
in A600 over time. Wild-type C. difficile UK1 initiated germination
in the presence of 5 mM TA and 50 mM TA but not in the
absence of TA (Figure 2A). However, spores derived from C.
difficile ger1 (Figure 2B) did not initiate germination even at the
highest TA concentration used (50 mM). Also, while wild-type C.
difficile released DPA in response to TA and glycine, C. difficile ger1–
ger10 spores were unable to release the majority of the stored DPA
(Figure 2C); Ca++-DPA release from the spore core is one of the
first measurable events in bacterial spore germination [10].
Together, these results suggest that the C. difficile ger isolates are
defective in the earliest stages of spore germination and may be
defective in recognizing TA as a germinant.
Determining the locations of SNPs that give rise to ger
phenotype
The locations of the SNP(s) that gave rise to the germination-
null phenotypes were determined using Illumina sequencing
technology (Table S1). The DNA sequence of the 10 ger isolates
were compared to determine if all had mutations in the same locus
or loci. All isolates had in common mutations in 7 loci, with 6 loci
having conserved mutations among all isolates (Table 1). Interest-
ingly, C. difficile ger1–ger10 had several different mutations in the
cspBAC locus (Table 2). In Clostridium perfringens, CspA, CspB and
CspC are germination-specific proteases that cleave the spore
cortex lytic enzyme, SleC, to the active form [22,23,24]. This
allows precise control of the timing of cortex hydrolysis during
germination. C. perfringens CspA, CspB and CspC, all members of
the subtilisin-family of proteases, have identifiable catalytic triads,
while, in C. difficile, only CspB has obvious catalytic residues. In
wild-type C. difficile, cspB and cspA coding sequences have been
fused. Further, the CspA and CspC catalytic triads appear to have
been lost (Figure S1). Eight of the 10 mutant strains had mutations
in cspC (Table 2), suggesting that, despite the apparent absence of
catalytic activity, wild-type CspC may still have a role in C. difficile
spore germination.
Defining the role of C. difficile cspC during spore
germination
To investigate the role of CspC in C. difficile spore germination,
we generated a site-directed mutation using TargeTron technol-
ogy [4,25,26,27,28]. The resulting strain, C. difficile JSC10
(cspC::ermB), is unable to initiate germination in response to TA
(Figure 3B) unless provided with the cspBAC locus expressed in trans
from a plasmid (Figure 3C); wild-type C. difficile UK1 initiates
germination in response to TA (Figure 3A). Interestingly, when C.
Author Summary
Clostridium difficile infections (CDI) are steadily increasing
in the United States and other countries. C. difficile spores
are the infectious agent and often contaminate environ-
mental surfaces. However, to initiate infection, C. difficile
spores must germinate in vivo to actively growing bacteria.
Certain bile acids and glycine are the most effective
compounds that stimulate C. difficile spore germination.
While the signals that stimulate germination by C. difficile
spores are known, with what these compounds interact
remained unknown. Here, we identified the germination-
specific protease, CspC, as the bile acid germinant
receptor. In C. difficile, CspC is not predicted to have
catalytic activity. However, we find that mutations in cspC
alter the specificity of germinant recognition or abrogate
the ability of C. difficile spore to germinate in response to
bile acids. Further, we show that bile acid recognition by C.
difficile spores is important for establishing infection in an
animal model of C. difficile disease. Our results suggest a
unique mechanism for C. difficile spore germination
through direct stimulation of cortex hydrolysis by a spore
germinant. A detailed understanding of germinant recog-
nition by C. difficile CspC may aid in the identification of
germination-blocking compounds, which may have im-
portance in hindering C. difficile colonization.
C. difficile CspC Is a Germinant Receptor
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difficile JSC10 was complemented with the cspBAC locus, spores
generated from this strain appear to germinate more rapidly than
do C. difficile UK1 spores. Further work will be needed to
characterize the germination rates of these spores. When analyzed
for DPA release, wild-type C. difficile UK1 and C. difficile JSC10
(pJS123) released DPA while C. difficile JSC10 was unable to
release DPA (Figure 3D).
Mutations in cspC can alter germinant specificity
It was previously reported that a mutation in sleC prevents C.
difficile spore germination [27]. Thus, mutations that affect
germination do not necessarily indicate that the gene in which
the mutation lies normally codes for a germinant receptor. To test
the hypothesis that C. difficile CspC is a bona fide germinant
receptor, we again mutagenized C. difficile UK1 and allowed the
mutagenized bacteria to form spores. The purified spores were
plated on BHIS medium supplemented with 0.5 mM chenodeoxy-
cholic acid. We looked for colony formation after 48 hours of
incubation at 37uC. Chenodeoxycholic acid is a competitive
inhibitor of cholic acid-mediated germination for C. difficile UK1
[18,19] and other C. difficile strains [29]. Thus, in order to form
colonies, these spores must have acquired an altered germinant
specificity. Colonies were isolated and the phenotype confirmed as
described above. We sequenced cspC from these newly generated
strains and identified a single mutation, G457R. When the
cspCG457R allele was used to complement C. difficile JSC10, we
observed that this strain germinated in response to either TA or
chenodeoxycholic acid (Figure 4). These results suggest that C.
difficile CspC is a receptor for bile acid germinants.
Bile acid-mediated germination is important for C. difficile
infection in hamsters
The in vivo signals that trigger C. difficile spore germination are
unknown, though bile acids are obvious candidates [30]. To test
whether bile acid-mediated germination is required for C. difficile
infection, Syrian hamsters were treated with clindamycin to induce
sensitivity to C. difficile colonization and infection; the Syrian
hamster has been used for approximately 30 years to assess C.
difficile virulence and recapitulates the most severe form of human
C. difficile infection, pseudomembranous colitis [31]. Hamsters
were gavaged with 1,000 C. difficile UK1 spores or C. difficile JSC10
spores or C. difficile JSC10 (pJS123) spores and monitored for signs
of CDI. Animals infected with either C. difficile UK1 or C. difficile
JSC10 (pJS123) rapidly succumbed to disease. However, C. difficile
JSC10 was unable to cause fulminant CDI and exhibited reduced
virulence (Chi-squared: p-value,0.02) (Figure 5). These results
show that bile acid-mediated germination is important for C.
difficile disease and suggest that inhibiting C. difficile spore
germination may have therapeutic potential.
Discussion
Classically, germinant receptors are embedded within the inner
membrane of bacterial spores [10,32]. Germinants must pass
through layers of coat proteins, an outer membrane, the cortex
and germ cell wall before interacting with their respective
receptors. Upon interaction, Ca++-DPA is released from the spore
core in exchange for water. This exchange is essential to rehydrate
the core and allow metabolism to begin. In some bacteria, the
release of Ca++-DPA triggers the activation of cortex hydrolases
allowing a vegetative bacterium to grow from the germinating
spore [33]. In C. perfringens the germination-specific proteases
cleave the cortex hydrolase, SleC, to an active form [23,24]. The
signals that stimulate this proteolysis in C. perfringens are not known.
In C. perfringens, CspA, CspB and CspC are all members of the
subtilisin family of serine proteases and have complete catalytic
triads, suggesting that any one of these proteins can activate SleC-
mediated cortex hydrolysis. In C. difficile, the cspB and cspA coding
sequences have been fused [34]. Only CspB contains a complete
catalytic triad while CspA and CspC have lost their catalytic
residues. Based on sequence analysis, one would predict that only
CspB would have an active role in stimulating C. difficile cortex
Figure 1. Isolation of C. difficile germination-null mutants. (A) Strategy to identify C. difficile ger phenotypes. Spores were generated (1) and
purified (2). After purification, spores were germinated in BHIS medium supplemented with TA (3) and germinated spores heat-killed at 65uC (4).
Spores that survived (4) were artificially germinated (5) before plating on BHIS medium (6). (B) C. difficile UK1 spores or C. difficile ger1 spores were
serially diluted and spotted on BHIS medium supplemented with 0.1% TA or germinated by thioglycollate/lysozyme and were serially diluted and
spotted on BHIS medium.
doi:10.1371/journal.ppat.1003356.g001
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hydrolysis. Indeed, a recent study by Adams and colleagues has
shown that CspBA undergoes autoprocessing to generate CspB,
which can cleave the cortex hydrolase pro-SleC to an active form
[34]. We have provided evidence that C. difficile CspC plays an
active and essential role during germination by functioning as the
bile acid germinant receptor.
In C. difficile CspC, two of the three catalytic residues have been
lost, T170 (conserved H198 in C. perfringens CspC) and G485
(conserved S517 in C. perfringens CspC) (Figure S1 – red).
Interestingly, several the SNPs identified in the germination-null
screen lie near T170 or G485 (Figure S1 – green). When we
screened for C. difficile mutants that germinated in response to an
inhibitor of germination (chenodeoxycholic acid), we identified
G457R (Figure S1 – yellow). This residue is approximately 30
amino acids removed from G485. G457R, being a fairly drastic
substitution, may modify the bile acid binding pocket to allow for a
less-stringent recognition of germination-inducing bile acids. The
12a-hydroxyl group that differentiates between cholic acid and
chenodeoxycholic acid protrudes from the molecule. This
hydroxyl, in wild-type CspC, may penetrate the hypothetical
binding pocket, resulting in a conformational change that is
transmitted to C. difficile CspB [34]. CspB would then cleave SleC,
initiating cortex hydrolysis [34]. Two of the identified SNPs in the
germination-null screen were nonsense mutations in cspBA
(Q632stop and W359stop). In the CspBA hybrid protein, Q632
is located in CspA while W359 is in CspB. The generation of a
premature stop codon in cspB would result in a truncated protein
with an incomplete catalytic triad [34]. The precise role of CspA
in C. difficile spore germination is unknown, though our data
suggest that CspA may be important.
Our data indicate that host-derived bile acids mediate C. difficile
spore germination and that recognition of bile acids is required for
infection in the hamster model to be maximally effective. Still,
50% of the animals succumbed to disease when infected with the
cspC mutant, suggesting (i) that enough spores spontaneously
germinated in the GI tract of the animal to cause disease, or (ii)
that other, as yet unidentified, host signals can stimulate spore
germination. Lysozyme is able to induce germination of C. difficile
spores in vitro [21]. However, recent evidence has suggested that
lysozyme at physiological levels may not be able to stimulate C.
difficile spore germination [35] and we observe most efficient
lysozyme-mediated spore germination after spore coat removal.
Further study will be needed to determine if other signals provided
by the host can stimulate C. difficile spore germination.
Previously, we identified inhibitors of C. difficile spore germina-
tion that had increased potency when compared to chenodeoxy-
cholic acid [19]. It is not yet known whether these germination
inhibitors have therapeutic importance but a recent study by
Figure 2. C. difficile ger isolates fail to initiate germination. Purified C. difficile UK1 spores (A) or C. difficile ger1 spores (B) were suspended in
BHIS medium (N) or BHIS medium supplemented with 5 mM TA (&) or 50 mM TA (m) and the initiation of germination was followed at A600. (C) DPA
release from spores suspended in germination buffer supplemented with TA and glycine was analyzed at A270.
doi:10.1371/journal.ppat.1003356.g002
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Howerton and coworkers has shown dosing antibiotic-treated
mice with an inhibitor of germination can reduce disease
severity [36]. The identification of the molecular target of bile
acids in the C. difficile spore may allow even more potent
inhibitors to be rationally designed. Further, these inhibitors
may aid in the identification in the bile acid-binding pocket in
CspC by providing high-affinity interaction, instead of the
relatively low affinity (in the mM range) for taurocholic acid
[19,37].
The relative affinities of bile acids for the C. difficile spore were
determined using kinetics of germination [18,19,37,38,39]. While
these studies were important milestones in determining which bile
acids affect C. difficile germination and what features are important
for triggering or inhibiting germination, the precise interaction of
the bile acid with the germinant receptor has not been analyzed.
Also, it has been proposed that the bile acid germinant receptor
binds taurocholic acid cooperatively [37]. The identification of the
bile acid germinant receptor now permits testing these interac-
tions.
Stimulation of cortex hydrolysis may not be sufficient to fully
activate C. difficile spore germination. C. difficile spores suspended in
buffered taurocholic acid alone do not initiate spore germination
unless a co-germinant, glycine, is added [17]. This suggests that a
second, glycine-sensing receptor is required to trigger germination
and the return to vegetative growth. We hypothesize that this
other receptor may be localized to the inner membrane to aid in
the release of Ca++-DPA from the spore core during germination.
Materials and Methods
Ethics statement
All animal procedures were performed with prior approval from
the Texas A&M Institutional Animal Care and Use Committee.
Animals showing signs of disease were euthanized by CO2
asphyxia followed by thoracotomy as a secondary means of death,
in accordance with Panel on Euthanasia of the American
Veterinary Medical Association. Texas A&M University’s approv-
al of Animal Use Protocols is based upon the United States
Government’s Principles for the Utilization and Care of Verte-
brate Animals Used in Testing, Research and Training and
complies with all applicable portions of the Animal Welfare Act,
the Public Health Service Policy for the Humane Care and Use of
Laboratory Animals, and all other federal, state, and local laws
which impact the care and use of animals.
Bacterial strains and growth conditions
C. difficile UK1 [19] (Table 3) was grown in a Model B, Coy
Laboratory Chamber at 37uC under anaerobic conditions (85%
nitrogen, 10% hydrogen, 5% carbon dioxide) in BHIS medium
(Brain Heart Infusion supplemented with 5 g/L yeast extract and
0.1% L-cysteine). Antibiotics were added as needed (20 mg/ml
thiamphenicol, 10 mg/ml lincomycin, 5 mg/ml rifampin). E. coli
DH5a [40] was routinely grown at 37uC in LB medium.
Antibiotics were added as needed (50 mg/ml kanamycin or
20 mg/ml chloramphenicol). Bacillus subtilis was grown at 37uC
in LB medium and antibiotics were added as needed (2.5 mg/ml
chloramphenicol, 5 mg/ml tetracycline).
EMS mutagenesis
One overnight culture of C. difficile UK1 was diluted 1:100 in
5 ml fresh medium and grown to OD600 = 0.5 before adding ethyl
methanesulfonate (EMS) to 1% final concentration. The culture
was incubated for 3 hours, washed in BHIS medium and
recovered overnight in 40-ml BHIS. A sample was taken to score
mutation frequency on rifampin-containing BHIS agar medium
(Table S2) and 50-mL samples were spread on 20 BHIS plates to
allow spore formation of the mutagenized bacteria. Plates were
incubated for 4 days before spores were harvested and purified as
described previously [19]. Purified spores were suspended in 40 ml
BHIS+10% w/v taurocholic acid (TA) and incubated overnight at
37uC to germinate those spores that recognized TA as a
germinant. Spores were collected and heated to 65uC for 1 hour
to inactivate germinated spores (dormant spores are resistant to
65uC). To germinate the remaining dormant spores, spores were
again collected and treated with 250 mM thioglycollate for 30 min
at 50uC followed by incubation with 4 mg/ml lysozyme for
15 min at 37uC [21] and 25-mL aliquots were spread on BHIS
agar plates to allow spore formation. To enrich for germination
null phenotypes, spores were again collected and germinated as
described above.
To select for mutations that change the affinity of the germinant
receptor from TA to chenodeoxycholic acid, C. difficile UK1 was
mutated as described above with the following modification.
Purified spores generated from mutated bacteria were spread on
BHIS medium supplemented with 0.5 mM chenodeoxycholic
acid. Colonies from spores that germinated on this medium were
purified and the germination phenotype of their spores was
confirmed using standard germination techniques (below).
Table 1. Locations of the SNPs common to all 10 C. difficile
ger isolates. Gene numbering is based upon C. difficile R20291
gene numbering.
Location Mutation Putative Function
Nt 129662 CRT N/A
CD901 No aa change Pseudogene
CD1323 Q138K Putative rubrerythrin
CD1848 S308A Putative peptidase
CD1913 K82fs AraC-family transcriptional activator
CD2020 P211L Putative histidine protein kinase
CspBAC Various (see Table 2) Germination-specific protease
Nt: nucleotide.
aa: amino acid.
fs: frame shift.
doi:10.1371/journal.ppat.1003356.t001
Table 2. Locations of C. difficile cspBAC mutations in the ger
mutants.
Strain Mutation(s)
ger1 CspC G171R
ger2 CspC G171R
ger3 CspC G483R
ger4 CspC V272G/S443N
ger5 CspBA Q632stp
ger6 CspC S488N
ger7 CspBA W359stp
ger8 CspC G171R
ger9 CspC G483R
ger10 CspC G276R
stp: stop codon.
doi:10.1371/journal.ppat.1003356.t002
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Illumina sequencing
High-quality, high-molecular weight genomic DNA was
extracted, as described previously [41,42], and submitted to Tufts
University School of Medicine Genomics Core facility for Paired-
End 50 Illumina re-sequencing. The samples were sonicated in a
4uC water bath with a Branson sonicator. Illumina libraries were
then prepared using the Illumina TruSeq genomic DNA kit and
tagged with individual Illumina barcodes. Final libraries were
checked on said advanced analytical device, and then diluted to
10 nM prior to being loaded on a lane of an Illumina HiSeq2000.
Illumina single-end sequencing was carried out for 50 cycles. The
resulting sequence data in fastq format was aligned against the C.
difficile R20291 genome using CLC Genomics Workbench, and
SNPs were called at any position where more than 66% of the
reads had an alternate base from the reference
Molecular biology
The Tn916 oriT from Bacillus subtilis Bs49 was amplified using
oligonucleotides 59Tn916SLIC and 39Tn916SLIC (Table 4) and
introduced into the BstAPI restriction site of pBL100 [43] using
Sequence and Ligation Independent Cloning (SLIC), generating
pJS107. The pJS107 plasmid was used as a TargeTron vector to
introduce mutations in to C. difficile. The group II intron insertion
sites for C. difficile cspC were identified using an algorithm that can
be found at http://dna.med.monash.edu.au/,torsten/
intron_site_finder/. The intron fragment was generated as
described previously using oligonucleotides cspC (115) EBS2,
cspC (115) IBS, cspC (115) EBS1 and EBSU, cloned into pCR2.1-
TOPO and then sub-cloned at the HindIII and BsrGI sites of
pJS107, yielding pJS130. The B. subtilis – C. difficile shuttle vector,
pJS116, was generated through the introduction of the Tn916 oriT
into the ApaI restriction site of the E. coli – C. difficile shuttle vector,
pMTL84151 [44], using oligonucleotides 59Tn916ApaI and
39Tn916ApaI which amplify the Tn916 oriT. The C. difficile
cspBAC loci were amplified with Phusion polymerase using
59cspBA_CXbaI and 39cspBA_CXhoI oligonucleotides and
cloned into the B. subtilis – C. difficile shuttle vector, pJS116. The
nucleotide sequences for all constructs were confirmed before use.
Conjugation and mutant selection
B. subtilis BS49 was used as a donor for conjugation with C.
difficile. Plasmids were introduced into B. subtilis BS49 using
Figure 3. C. difficile cspC is essential for bile acid-mediated spore germination. Purified C. difficile UK1 spores (A) or C. difficile JSC10
(cspC::ermB) spores (B) or C. difficile JSC10 (cspC::ermB) pJS123 (pcspBAC) (C) were suspended in BHIS medium (N) or BHIS medium supplemented
with 5 mM TA (&) or 50 mM TA (m) and the initiation of germination was followed at A600. (D) DPA release from spores suspended in germination
buffer supplemented with TA and glycine was analyzed at A270.
doi:10.1371/journal.ppat.1003356.g003
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standard techniques. Conjugation experiments were carried out as
described previously [28]. C. difficile transconjugants were screened
for the presence of Tn916 using tetracycline resistance. Thiam-
phenicol-resistant, tetracycline-sensitive (plasmid-containing,
transposon negative) transconjugants were selected for further
use. Potential TargeTron mutants were generated by screening
lincomycin-resistant C. difficile for the insertion of the intron into C.
difficile cspC using primers specific for full-length C. difficile cspC, the
59 intron insertion site and the 39 intron insertion site and a
positive clone was identified, C. difficile JSC10.
Spore germination and DPA release
Spores were purified from BHIS agar medium as described
previously [19] with the following modification. Spores from
antibiotic-resistant strains (i.e. plasmid-containing or mutant
strains) were generated on SMC medium [45] supplemented with
appropriate antibiotics and purified as described previously. The
initiation of spore germination was analyzed in a Lambda 25
Perkin Elmer spectrophotometer at A600 every 18 seconds, as
Figure 4. Mutations in C. difficile cspC can alter germination
specificity. Purified C. difficile JSC10 (cspC::ermB) pJS144
(pcspBACG457R) spores were suspended in BHIS medium (N) or BHIS
medium supplemented with 1 mM chenodeoxycholic acid (m) or 5 mM
chenodeoxycholic acid (.) or 10 mM TA (&) and the initiation of
germination was followed at A600.
doi:10.1371/journal.ppat.1003356.g004
Figure 5. Bile acid-mediated germination is required for
virulence. Kaplan-Meier survival curve of clindamycin-treated Syrian
hamsters inoculated with 1,000 spores of C. difficile UK1 or C. difficile
JSC10 (cspC::ermB) or C. difficile JSC10 (cspC::ermB) pJS123 (pcspBAC).
Animals showing signs of C. difficile infection (wet tail, poor fur coat,
lethargy) were euthanized.
doi:10.1371/journal.ppat.1003356.g005
Table 3. Strains and plasmids used in this study.
Strain Description/Phenotype Reference
E. coli DH5a F2 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG W80dlacZDM15 D(lacZYA-argF)U169, hsdR17(rK
2 mK
+), l– [40]
B. subtilis Bs49 Tn916 donor strain, TetR [48]
C. difficile UK1 Wild type, PCR ribotype 027 [19]
C. difficile JSC10 cspC TargeTron mutant, germination null This study
Plasmids
pMTL84151 E. coli-C. difficile shuttle vector (pCD6 ColE1 traJ CmR) [44]
pBL100 TargeTron vector [43]
pJS107 Tn916 oriT in pBL100 This study
pJS116 B. subtilis-C. difficile shuttle vector (pCD6 ColE1 Tn916 oriT CmR) This study
pJS123 cspBAC locus cloned in pJS116, complements cspC mutation This study
pJS130 cspC-targeted TargeTron in pJS107 This study
pJS144 cspBACG457R locus cloned in pJS116 This study
doi:10.1371/journal.ppat.1003356.t003
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described previously [17,18,19]. DPA release was measured by
incubating purified spores at 37uC in germination salts (0.3 mM
(NH4)2SO4, 6.6 mM KH2PO4, 15 mM NaCl, 59.5 mM
NaHCO3 and 35.2 mM Na2HPO4) supplemented with 10% TA
and 1 mM glycine for 1 hour. Equal aliquots were incubated at
100uC as a measure of 100% DPA release (positive control) or
incubated at 37uC in germination salts without TA addition
(negative control). Spores were sedimented and the supernatant
was analyzed at A270 to measure the released DPA [46].
Virulence studies
Female Syrian golden hamsters, 80 g–120 g, were housed
individually in cages and had ad libitum access to food and water for
the duration of the experiment. To induce susceptibility to C.
difficile infection, hamsters were gavaged with 30 mg/kg clinda-
mycin [31,47]. After 5 days, hamsters were gavaged with 1,000
spores of C. difficile UK1 or C. difficile JSC10 or C. difficile JSC10
pJS123, 10 animals per strain, and monitored for signs of disease
(lethargy, poor fur coat and wet tail). Hamsters showing signs of
disease were euthanized by CO2 asphyxia followed by thoracot-
omy as a secondary means of death in accordance with Panel on
Euthanasia of the American Veterinary Medical Association. Fecal
samples were collected daily and cecum samples were collected on
those hamsters requiring euthanasia. All animal studies were
performed with prior approval from the Texas A&M University
Institutional Animal Care and Use Committee.
Statistical analyses
Experiments were performed in triplicate and, where indicated,
error bars represent 1 standard deviation from the mean. A
representative sample for the initiation of germination experiments
at A600 is shown, error bars obscure the data. The data varied by
,5%. Statistical significance of DPA release was performed using
the Student’s T-test. Differences in hamster survival between those
infected with C. difficile JSC10 and either C. difficile UK1 or C.
difficile JSC10 pJS123 were analyzed using the Log-rank test
(GraphPad Prism).
Supporting Information
Figure S1 Sequence alignment between C. difficile CspC
and C. perfringens CspC. C. difficile CspC and C. perfringens
CspC protein sequence alignments were performed with the
Interactive Structure based Sequences Alignment Program
(STRAP) using the ClustalW method. The locations of the
catalytic residues for C. perfringens CspC, a subtilisin-like protease,
were identified using the MEROPS database, which is maintained
by the Wellcome Trust Sanger Institute. Catalytic residues (red),
SNPs identified in the germination-null screen (green), SNP that
alters germinant specificity (yellow).
(TIF)
Table S1 Locations of the identified SNPs of the re-
sequenced C. difficile ger isolates. The locations of the
identified SNPs of the re-sequenced C. difficile germination-null
mutants are indicated. The 10 re-sequenced strains are color-
coded in the table to aid in their identification. The position in the
R20291 genome (Reference Position), the position in the re-
sequenced UK1 genome (Consensus Position), the type of
mutation (Variation Type), the number of nucleotides changed
(Length), wild-type nucleotide sequence (Reference), the total
number of variants (Variants), the identified SNP (Allele
Variations), frequency of the identified SNPs at the given position
(Frequencies), the number of reads that identified the SNP
(Counts), the total number of reads at the position (Coverage),
the called SNP (Variant #1), the frequency of the called SNP
(Frequency of #1), the total number of reads of the called SNP
(Count of #1), the annotation (Overlapping Annotations) and the
impact of the mutation on the coding sequence (Amino Acid
Change) are listed.
(XLSX)
Table S2 Frequency of rifampin-resistant C. difficile
UK1. Exponential phase C. difficile cultures were exposed to EMS
and then plated on agar medium or medium supplemented with
rifampin. Wild-type, untreated C. difficile was included as a control.
(DOCX)
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Table 4. Oligonucleotides used in this study.
59Tn916SLIC 59 – GCAGATTGTACTGAGAGTGCACCATTAA CAT CTTCTA TTTTTCCCAAATCC – 39
39Tn916SLIC 59 – ATCTGTGCGGTATTTCACACCGCATCTAAAGGGAATGTAGATAAATTATTAGGTAATC – 39
cspC (115) EBS2 59 – TGAACGCAAGTTTCTAATTTCGGTTAAAATCCGATAGAGGAAAGTGTCT – 39
cspC (115) IBS 59 – AAAAAAGCTTATAATTATCCTTAATTTTCAATAATGTGCGCCCAGATAGGGTG – 39
cspC (115) EBS1 59 – CAGATTGTACAAATGTGGTGATAACAGATAAGTCAATAATATTAACTTACCTTTCTTTGT – 39
EBSU 59 – CGAAATTAGAAACTTGCGTTCAGTAAAC – 39
59Tn916ApaI 59 – AAGGGCCCTAACATCTTCTATTTTTCCCAAATCC – 39
39Tn916ApaI 59 – AAGGGCCCCTAAAGGGAATGTAGATAAATTATTAGGTAATC – 39
59cspBA_CXbaI 59 – AATCTAGAAAAACTATAAAGTTATAATTGTTGG – 39
39cspBA_CXhoI 59 – AACTCGAGCTATAGAGTATTTGCTATCTGTTGA – 39
doi:10.1371/journal.ppat.1003356.t004
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